A Medical Claims Database Study of Factors Associated with Medication Adherence and Treatment Persistence in Patients Receiving PCSK9 Monoclonal Antibodies-Reference-Cited by-同舟云学术

A Medical Claims Database Study of Factors Associated with Medication Adherence and Treatment Persistence in Patients Receiving PCSK9 Monoclonal Antibodies

Published:2024 Issue: Volume: Page:
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Takahashi Yuri¹,Morimoto Takeshi²,Iekushi Kazuma¹,Arai Hidenori³

Affiliation:

1. Medical Affairs Division, Novartis Pharma K.K.

2. Department of Clinical Epidemiology, Hyogo Medical University

3. National Center for Geriatrics and Gerontology

Publisher

Japan Atherosclerosis Society

Link

https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_64848/_pdf

Reference42 articles.

1. 1) Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro-Cardiovascular Diseases: Comprehensive risk management for the prevention of cerebro-cardiovascular diseases in Japan. Hypertens Res, 2017; 40: 847-855

2. 2) World Heart Federation: Deaths from cardiovascular disease surged 60% globally over the last 30 years: report. Available from: https://world-heart-federation.org/news/deaths-from-cardiovascular-disease-surged-60-globally-over-the-last-30-years-report/. Accessed: 27 September 2023

3. 3) Musunuru K: Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids, 2010; 45: 907-914

4. 4) Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S and Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA, 1986; 256: 2835-2838

5. 5) Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT and Gudnason V: Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262, 525 participants in 29 Western prospective studies. Circulation, 2007; 115: 450-458